Proteome Sciences (LON:PRM) Stock Price Down 15.8% – What’s Next?

Proteome Sciences plc (LON:PRM)’s stock price dropped 15.8% during mid-day trading on Wednesday . The company traded as low as GBX 1.60 and last traded at GBX 1.60. Approximately 191,895 shares traded hands during trading, a decline of 53% from the average daily volume of 406,055 shares. The stock had previously closed at GBX 1.90.

Proteome Sciences Price Performance

The firm has a market cap of £7.01 million, a PE ratio of -1.92 and a beta of 0.15. The firm’s fifty day simple moving average is GBX 1.63 and its two-hundred day simple moving average is GBX 1.82. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.